Dec 24, 2023, 18:54
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter:
“Exciting news that Belzutifan is approved by the FDA based on a study led by Toni Choueiri, offering a new treatment option for patients with advanced kidney cancer previously treated with immune checkpoint inhibitors and anti-angiogenic therapies.”
To read the article click here.
Source: Laurie Glimcher/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 2, 2025, 19:03
Apr 2, 2025, 18:42
Apr 2, 2025, 18:29
Apr 2, 2025, 18:23
Apr 2, 2025, 18:14
Apr 2, 2025, 18:01
Apr 2, 2025, 17:58